Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CLRB
Stock Latest News
Ratings
Cellectar Therapeutics: Advancing Targeted Radiotherapeutics with Clear Clinical Catalysts Supporting a Buy Rating and $10 Price Target
16d ago
CLRB
Premium
The Fly
Cellectar Biosciences enrolls first patient in CLR 121125 trial
17d ago
CLRB
Premium
The Fly
Cellectar Biosciences upgraded to Buy from Hold at Maxim
2M ago
CLRB
Premium
Company Announcements
Cellectar Biosciences Charts Risky Path to Approvals
2M ago
CLRB
Premium
The Fly
Cellectar Biosciences price target lowered to $14 from $18 at Roth Capital
2M ago
CLRB
Premium
The Fly
Cellectar Biosciences reports FY25 EPS ($8.35) vs ($41.89) last year
2M ago
CLRB
Premium
Pre-Earnings
CLRB Upcoming Earnings Report: What to Expect?
2M ago
CLRB
Premium
The Fly
Five new option listings and fourteen option delistings on February 23rd
2M ago
PHB
PIN
Premium
The Fly
Cellectar Biosciences expands global intellectual property estate
2M ago
CLRB
Premium
Company Announcements
Cellectar Advances CLR 125 Into Early Breast Cancer Trial, Adding Depth to Its Radiotherapy Pipeline
4M ago
CLRB
Premium
The Fly
Cellectar Biosciences to highlight company’s 2026 strategic initiatives
4M ago
CLRB
Premium
The Fly
Cellectar Biosciences announces supply agreement with Ionetix
5M ago
CLRB
Premium
Company Announcements
Cellectar Biosciences Reports Q3 2025 Financial Progress
6M ago
CLRB
Premium
Company Announcements
Cellectar Biosciences: Positive Outlook Amidst Challenges
6M ago
CLRB
Premium
The Fly
Cellectar Biosciences reports Q3 EPS ($1.41), consensus ($2.53)
6M ago
CLRB
Premium
Pre-Earnings
Cellectar Biosciences Inc (CLRB) Q3 Earnings Cheat Sheet
6M ago
CLRB
Premium
The Fly
Cellectar Biosciences receives RPDD from U.S. FDA for iopofosine I 131
6M ago
CLRB
Premium
The Fly
Cellectar Biosciences files to sell 2.1M shares of common stock for holders
6M ago
CLRB
Premium
The Fly
Cellectar Biosciences presents posters at AACR on CLR 121225, CLR 225
7M ago
CLRB
Premium
Company Announcements
Cellectar Biosciences Raises $5.8M Through Warrant Exercise
7M ago
8K
CLRB
Premium
The Fly
Cellectar Biosciences enters agreements to raise $5.8M
7M ago
CLRB
Premium
The Fly
EMA news ‘a substantial positive catalyst’ for Cellectar, says Oppenheimer
7M ago
CLRB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
